US Broker Ratings

PACS Group, Inc. (PACS) Stock Analysis: Exploring a 11.87% Potential Upside in Healthcare

PACS Group, Inc. (NASDAQ: PACS), a prominent player in the healthcare sector, particularly in medical care facilities, has been gaining attention from investors due to its..

Ascentage Pharma Group Internat (AAPG) Investor Outlook: Unveiling a 151.75% Potential Upside in Biotech

For individual investors seeking high-reward opportunities in the biotech sector, Ascentage Pharma Group International (AAPG) presents a compelling case. This China-based clinical-stage biotechnology company is making..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: A Promising Upside of 83.38% for Biotech Enthusiasts

Viridian Therapeutics, Inc. (NASDAQ: VRDN) occupies a promising niche in the healthcare sector, specializing in biotechnology with a focus on developing treatments for serious and rare..

Ocular Therapeutix, Inc. (OCUL): Investor Outlook Reveals a 213.55% Potential Upside in Biotech Stock

Ocular Therapeutix, Inc. (NASDAQ: OCUL) stands at an intriguing juncture for investors, offering an impressive potential upside of 213.55% as per current analyst ratings. This biopharmaceutical..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Navigating a Novel Bioelectric Frontier with a $2.27 Billion Market Cap

Pulse Biosciences, Inc. (NASDAQ: PLSE) stands as a compelling entity in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Immunocore Holdings plc (IMCR): Investor Outlook on Potential 88% Upside in the Biotech Arena

Immunocore Holdings plc (NASDAQ: IMCR) is carving a niche in the biotechnology sector, commanding attention with an enticing potential upside of 88.01%, according to analyst ratings...

PGIM Securitized Income ETF (PINC): A Stable Prospect in Securitized Credit Investments

Investors on the hunt for stability with a focus on securitized credit investments might find PGIM Securitized Income ETF (PINC) a notable option. With a market..

Harrow, Inc. (HROW) Stock Analysis: Robust Buy Ratings Signal Potential 80% Upside

Harrow, Inc. (NASDAQ: HROW), a leader in the eyecare pharmaceutical sector, has captured the attention of investors with its impressive array of ophthalmic products and an..

LeMaitre Vascular, Inc. (LMAT) Investor Outlook: Potential Upside of 20.03% Amid Robust Revenue Growth

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is gaining attention for its promising..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A 55% Potential Upside Amidst Innovative Therapies

Investors eyeing the biotechnology sector will find Celldex Therapeutics, Inc. (NASDAQ: CLDX) a compelling opportunity, especially with a projected upside of 55.59% according to analysts’ average..

Evotec SE (EVO) Stock Analysis: Exploring a 96.5% Potential Upside Despite Current Challenges

Evotec SE (EVO), a prominent player in the healthcare sector, specializes in drug discovery and development with a focus on addressing a broad spectrum of diseases...

Certara, Inc. (CERT) Stock Analysis: A Healthcare Investment with Limited Upside Potential

Certara, Inc. (NASDAQ: CERT), a key player in the health information services industry, is gaining traction among investors with its innovative technology-driven services and software products...

Schrodinger, Inc. (SDGR) Stock Analysis: Understanding the 34.63% Potential Upside in Health Information Services

Schrodinger, Inc. (NASDAQ: SDGR), a prominent player in the Healthcare sector, specifically within Health Information Services, provides a unique investment opportunity with its innovative approach to..

Brookdale Senior Living Inc. (BKD) Stock Analysis: A Closer Look at its 26.59% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a leading operator in the healthcare sector’s medical care facilities industry, presents an intriguing opportunity for investors looking to capitalize..

Neogen Corporation (NEOG): Investor Outlook Reveals 28% Potential Upside Amid Challenging Metrics

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector, specifically within medical devices, has captured investor attention with its potential upside of 28.48%. Despite..

ARS Pharmaceuticals (SPRY) Stock Analysis: A Potential 364% Upside in Biotech Innovator

Investors looking for compelling opportunities in the biotechnology sector may find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) particularly intriguing. With a significant market cap of $571.99 million..

Amphastar Pharmaceuticals, Inc. (AMPH) Investor Outlook: Evaluating a 14.70% Potential Upside

Investors eyeing Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) may find the current market conditions intriguing, given the company’s promising 14.70% potential upside. Amphastar, a key player in..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth with Diverse Offerings in the Healthcare Sector

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a prominent player in the healthcare sector, is carving a niche in the drug manufacturing industry with its diverse portfolio that..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 45.60% Potential Upside in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) has been capturing attention in the biotechnology sector with its innovative approach to precision medicine oncology. With a market capitalization of..

Disc Medicine, Inc. (IRON) Stock Analysis: Unveiling a 36% Upside Potential in Biotech Innovation

Disc Medicine, Inc. (NASDAQ: IRON) is making waves in the biotechnology sector, attracting keen interest from investors with its innovative approach to hematologic disease treatment. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds